عنوان

Biochemistry and Molecular Genetics of Cancer Metastasis :

(Number (ISBN

1461322995

(Number (ISBN

9781461322993

Number

b536139

Title Proper

Biochemistry and Molecular Genetics of Cancer Metastasis :

General Material Designation

[Book]

Other Title Information

Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis Bethesda, Maryland - March 18-20, 1985

First Statement of Responsibility

edited by Karoly Lapis, Lance A. Liotta, Alan S. Rabson.

Place of Publication, Distribution, etc.

Boston, MA

Name of Publisher, Distributor, etc.

Springer US

Date of Publication, Distribution, etc.

1986

Specific Material Designation and Extent of Item

(356 pages).

Series Title

Developments in oncology, 41.

Text of Note

One --;Biochemistry and Molecular Biology Aspects --;1. Biochemical and molecular biology approaches to study cancer metastases --;2. Use of the chick embryo in studying the molecular genetics of metastasis --;3. Integral membrane adhesion glycoproteins: What is their fate during metastasis? --;4. Peptide fragments of fibronectin and laminin: Role in cell adhesion and inhibition of experimental tumor metastasis --;5. Role of ras oncogenes in experimental models of metastasis --;6. Expression of p21ras gene products in fresh primary and metastatic human tumor tissue --;7. A role for differentiation arrest in the development of neural crest tumors --;8. Genetic and epigenetic regulation of the metastatic phenotype: A basis for resolving the controversy regarding its selective or random nature and variable phenotypic stability --;9. Cytochemical cell typing of metastatic tumors according to their cytoskeletal proteins --;10. Biochemistry and molecular biology RAW117 large cell lymphoma --;11. Karyotypic progression and metastasis formation of human tumors --;12. Morphological and functional alterations of occludens, adherens, and gap junctions in cancer --;13. Pattern of basement membrane degradation by metastatic tumor cell enzymes --;Two --;Immunologic Mechanisms --;14. Gene products of the major histocompatibility complex control the metastatic phenotype of tumor cells --;15. Generation of metastatic cells via somatic cell fusion: A possible mechanism for tumor progression in-vivo --;16. The recognition and destruction of metastatic cells by tumoricidal macrophages --;17. Biological response modifiers for the therapy of metastases --;18. Differences in cell surface characteristics of poorly and highly metastatic Lewis lung tumor variants --;19. Characteristics of LL2 and its lectin-resistant not metastasizing variants --;20. A role for cell surface sialic acid in liberating metastatic tumor cells from host control --;Three --;Clinical Perspectives and Applications --;21. Tumor heterogeneity and empirical clinical cancer chemotherapy: Current status and future prospects --;22. Hormonal regulation of metastases: Prospects for pharmacological manipulation --;23. Use of anti-tumor MABs for diagnosis and immunotherapy of human tumors --;24. New approaches to the adoptive immunotherapy of established metastatic cancer using lymphokine-activated killer cells and recombinant interleukin-2 --;25. Preclinical screening of biological response modifiers: Application to the treatment of metastatic disease.

Text of Note

Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985

Parallel Title

Proceedings of the Symposium on Biochemistry and Molecular Genetics of Cancer Metastasis, Bethesda, Maryland, March 18-20, 1985

Biochemistry.

Medicine.

Oncology.

Class number

Book number

edited by Karoly Lapis, Lance A. Liotta, Alan S. Rabson.

Alan S Rabson

Karoly Lapis

L A Liotta

Electronic name

[Book]

Y